Massive thrombi on an implantable cardioverter-defibrillator lead in a patient with the antiphospholipid syndrome

Europace

Volumn 13, Issue 8, 2011, Pages 1205-1206

  Ullah, Waqas ^a   Chambers, John B ^a   Hunt, Beverley J ^a   Blauth, Christopher ^a   Rinaldi, Christopher A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; ENOXAPARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CORONARY ARTERY THROMBOSIS; DEFIBRILLATOR; DEVICE REMOVAL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; PRIORITY JOURNAL; SHORT SURVEY; SUDDEN DEATH; THORAX PAIN;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ENDOCARDIUM; FEMALE; HUMANS; MIDDLE AGED; PERICARDIUM; THROMBOSIS; WARFARIN;

EID: 80051731131     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur070     Document Type: Short Survey

References (4)

1. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376:1498-509.
2. Tenedios F, Erkan D, Lockshin MD. Cardiac involvement in the antiphospholipid syndrome. Lupus 2005;14:691-6. (Pubitemid 41413293)
3. Kurisu S, Inoue I, Kawagoe T. Right atrial thrombosis after upgrading to a biventricular pacing/defibrillation system. Intern Med 2009;48:2101-4.
4. Chuang S, Mehta RH, Fay WP. Prolonged low-dose thrombolytic therapy: A novel adjunctive strategy in the management of an infected right atrial thrombus. Clin Cardiol 2002;25:346-9. (Pubitemid 34701115)